Global Anti Venom Market Size, Share, Growth, Trends, and Forecast (2024 - 2031)
Global Anti Venom Market Scope: Historical Data (2021 – 2022), Base Year (2023), Forecast Period (2024 – 2031)
Market Segmentation: By Animal Type (Snake, Scorpion, Spider, and Others), Type (Monovalent, and Polyvalent), Distribution Channel (Hospitals, Retail Pharmacies, and Others), and Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)
Market Overview
The Global Anti Venom Market was valued at USD 1,150.5 million in 2023 and is expected to reach USD 1,725.8 million by 2031 while growing at a CAGR of 5.2% during the forecast period (2024-2031).
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Market Dynamics
This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global anti venom market growth. Antivenoms function by enhancing our immune response following a snakebite. They are created by immunizing donor animals like horses or sheep with snake venoms. These animals possess strong immune systems, generating potent antibodies that bind to snake venom components, allowing our immune defenses to neutralize these toxins.
The market experiences growth driven by the high incidence of snakebites, improving access to healthcare, and advancements in manufacturing processes. However, high production costs and variability in venom composition serve as obstacles to market growth.
Furthermore, the global anti venom industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.
Segmentation – By Animal Type Analysis
The Global Anti Venom Market is segmented among Snake, Scorpion, Spider, and Others, based on Animal Type. In 2023, Snake accounted for the majority of the market share*.
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Segmentation – By Type Analysis
The Global Anti Venom Market is segmented among Traumatic Monovalent, and Polyvalent, based on Type. In 2023, Polyvalent accounted for the majority of the market share*.
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Global Anti Venom Market: Regional Analysis
Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Asia Pacific is expected to grow with the highest CAGR during the forecast period (2024 – 2031).
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Competitive Landscape
Some of the key players operating in the market are BTG plc. Laboratorios Silanes, CSL Limited, Pfizer, Inc, Merck & Co., Inc., Bharat Serums and Vaccines Limited, Haffkine Bio-Pharmaceutical Corporation Ltd., Vins Bioproducts Limited, Incepta Pharmaceuticals Ltd., and Rare Disease Therapeutics Inc.
Table of Contents:
1. Research Methodology and Market Scope
Research Methodology
Market Scope
2. Executive Summary
3. Global Anti Venom Market Dynamics
Drivers
Restraints
Opportunity
4. Global Anti Venom Industry Analysis
PEST Analysis
Porter's Five Force Analysis
Recent Deals Analysis
5. Global Anti Venom Market Segmentation, By Animal Type
Global Anti Venom Market Share Analysis, By Animal Type
Global Anti Venom Market Growth Analysis, By Animal Type
Global Anti Venom Market Trends, By Animal Type
o Snake
o Scorpion
o Spider
o Others
6. Global Anti Venom Market Segmentation, By Type
Global Anti Venom Market Share Analysis, By Type
Global Anti Venom Market Growth Analysis, By Type
Global Anti Venom Market Trends, By Type
o Monovalent
o Polyvalent
7. Global Anti Venom Market Segmentation, By Distribution Channel
Global Anti Venom Market Share Analysis, By Distribution Channel
Global Anti Venom Market Growth Analysis, By Distribution Channel
Global Anti Venom Market Trends, By Distribution Channel
o Hospitals
o Retail Pharmacies
o Others
8. Global Anti Venom Market Segmentation, By Region
Global Anti Venom Market Share Analysis, By Region
Global Anti Venom Market Growth Analysis, By Region
Global Anti Venom Market Trends, By Region
o North America
o Europe
o Asia Pacific
o Latin America
o Middle East
o Africa
9. Competitive Landscape
BTG plc.*
o Company Overview
o Financial Performance
o Key Development/Strategies
o SWOT Analysis
Laboratorios Silanes
CSL Limited
Pfizer, Inc.
Merck & Co., Inc.
Bharat Serums and Vaccines Limited
Haffkine Bio-Pharmaceutical Corporation Ltd.
Vins Bioproducts Limited
Incepta Pharmaceuticals Ltd.
Rare Disease Therapeutics Inc
*Similar analysis will be provided for each company listed above.